parafollicular cell
Summary
Parafollicular cells (C cells) are neuroendocrine cells of the thyroid that secrete calcitonin, which lowers serum calcium by inhibiting osteoclast activity. They derive from neural crest (via ultimobranchial body / 4th–5th pharyngeal pouch) and are the cell of origin of medullary thyroid carcinoma (MTC).
Detail
**Location/Histology:** Found in the interstitium between thyroid follicles (and in the upper-lateral lobes, where density is highest). They appear as pale-staining cells with clear cytoplasm on H&E and do not border the colloid. This distinguishes them from follicular cells, which make thyroglobulin and thyroid hormone.
**Embryology:** C cells arise from neural crest cells that migrate through the ultimobranchial body (4th/5th pharyngeal pouch derivative) and fuse with the median thyroid anlage (from the foramen cecum). Follicular cells are endodermal. Ectopic or residual tissue can persist in the lateral thyroid.
**Physiology:** - Secrete **calcitonin** in response to hypercalcemia (sensed by the calcium-sensing receptor, CaSR). - Calcitonin **inhibits osteoclast** bone resorption and increases renal calcium excretion. This lowers serum Ca²⁺ ("tones down" calcium). - Its role in humans is minor. Total thyroidectomy does not cause clinically significant calcium dysregulation from calcitonin loss. PTH and vitamin D are the dominant regulators. - Opposes PTH in net effect on bone.
**Pathology: Medullary thyroid carcinoma (MTC)** - Neuroendocrine tumor of C cells. It makes up about 5% of thyroid cancers. - Histology: sheets or nests of polygonal or spindle cells in an **amyloid stroma**. The amyloid is derived from calcitonin and stains with **Congo red** (apple-green birefringence under polarized light). - Tumor markers: elevated **calcitonin**, plus CEA. Chromogranin positive. - Can cause diarrhea (from calcitonin, VIP, or other peptides). The calcitonin level is not associated with hypocalcemia. - Spread: lymphatic spread to cervical nodes. It does not take up radioiodine, so RAI is ineffective. Treatment is total thyroidectomy with central neck dissection. - Genetics: **RET proto-oncogene** mutations (a receptor tyrosine kinase on chromosome 10). - **MEN 2A** (Sipple): MTC + pheochromocytoma + primary hyperparathyroidism (parathyroid hyperplasia) - **MEN 2B**: MTC + pheochromocytoma + mucosal neuromas/marfanoid habitus (no parathyroid disease) - **Familial MTC**: MTC only - Sporadic MTC also occurs (somatic RET mutations). - Prophylactic thyroidectomy is recommended in RET-positive family members. Always rule out pheochromocytoma before thyroid surgery to avoid a hypertensive crisis under anesthesia. Selective RET inhibitors (selpercatinib, pralsetinib) and vandetanib/cabozantinib are options for advanced disease.
**C-cell hyperplasia** is the precursor lesion in hereditary MTC.
**High-yield contrasts:** - Follicular cells: thyroglobulin, T3/T4, TSH-responsive, endoderm → papillary/follicular/anaplastic carcinoma - Parafollicular cells: calcitonin, neural crest, no TSH dependence → medullary carcinoma - Chief cells (parathyroid): PTH → raise calcium
**Mnemonic:** "C cells = Calcitonin = Carcinoma with Congo red amyloid; Calcitonin decreases Calcium (puts Ca in bone)."
Sources
- First Aid for the USMLE Step 1 (Endocrine: Thyroid pathology, MEN syndromes)
- Robbins & Kumar Basic Pathology (Thyroid gland, Medullary carcinoma)
- Guyton and Hall Textbook of Medical Physiology (Parathyroid hormone, calcitonin, calcium regulation)
- Pathoma (Fundamentals of Pathology, Endocrine chapter)
- Ross & Pawlina Histology: A Text and Atlas (Thyroid gland)
- Langman's Medical Embryology (Pharyngeal pouches, thyroid development)
- American Thyroid Association Guidelines for Management of Medullary Thyroid Carcinoma
Reviewed by Medusa editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.